z-logo
open-access-imgOpen Access
Elevated serum levels of interleukin -22 and interleukin-23 in pediatric asthma
Author(s) -
Baneen Ahmed Jabbar,
Abeer Thaher Naji AL-Hasnawi,
Aqeel Mahdi Hussein,
Haidar Abdul Amir Najim Abood,
Jalal Ali Ashour
Publication year - 2022
Publication title -
international journal of health sciences (ijhs) (en línea)
Language(s) - English
Resource type - Journals
eISSN - 2550-6978
pISSN - 2550-696X
DOI - 10.53730/ijhs.v6ns1.5690
Subject(s) - medicine , asthma , outpatient clinic , interleukin 5 , case control study , interleukin , immunology , gastroenterology , cytokine
Background: There are few studies had addressed the association between serum levels of Interleukin -22 and Interleukin-23 with severity of asthma, this study aims to evaluate whether elevated IL-22 and IL-23 serum levels is related to the severity of asthma. Methods: This study is a case-control study that included 60 asthmatic children (35 male and 25 female) as the patients group age ranged between 4 months to 14 years old, and 60 non-asthmatic (32 male and 28 female) age-matched patients group attending the outpatient clinic were recruited as control group. Serum levels of IL-22 and IL-23 was measured by sandwich ELISA using ELISA kits. Results: The results of this study have shown an elevated serum level of IL-23 in patients group compared with control group with significant (p= 0.008) and there was no significant difference between patients and control regarding IL-22 serum level (p = 0.721) in asthmatic children. Conclusion: According to the current study the serum level of IL-23 showing a significant association with the asthma severity in children.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here